| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2022 | Jul 14, 2022 | Vistagen Therapeutics, Inc. | 10% Owner | Sell | 40.0 | -60,000 | -0.29% | ✗ | $53.4K |
| Aug 14, 2020 | Aug 18, 2020 | Cogent Biosciences, Inc. | 10% Owner | Buy | 100.0 | +451,000 | 11.55% | ✗ | $1.1M |
| Jun 15, 2020 | Jun 15, 2020 | Altimmune, Inc. | 10% Owner | Buy | 100.0 | +1,500,000 | 50.00% | ✗ | $11.3M |
| May 26, 2020 | May 28, 2020 | Altimmune, Inc. | 10% Owner | Buy | 100.0 | +1,303,636 | 76.85% | ✗ | $11.4M |
| Mar 18, 2019 | Mar 20, 2019 | KalVista Pharmaceuticals, Inc. | 10% Owner | Sell | 15.0 | -500,000 | -24.46% | ✗ | $14.4M |
| Feb 26, 2018 | Feb 28, 2018 | Oruka Therapeutics, Inc. | 10% Owner | Sell | 20.0 | -1,541,331 | -100.00% | ✗ | $846.9K |
| Aug 5, 2014 | Aug 7, 2014 | Adverum Biotechnologies, Inc. | 10% Owner | Buy | 100.0 | +400,000 | 20.35% | ✗ | $6.8M |